- Home
- RCUS vs TCBI Comparison
RCUS vs TCBI Comparison
Compare RCUS & TCBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | TCBI |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1785 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCUS | TCBI |
|---|---|---|
| Price | $28.92 | $102.36 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | $31.90 | ★ $100.92 |
| AVG Volume (30 Days) | ★ 1.6M | 534.5K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.81% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $14.76 |
| Revenue Next Year | $45.62 | $7.47 |
| P/E Ratio | ★ N/A | $15.46 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.84 | $75.41 |
| 52 Week High | $31.74 | $108.92 |
Technical Indicators
Market Signals| Indicator | RCUS | TCBI |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 52.76 |
| Support Level | $22.79 | $97.23 |
| Resistance Level | $31.74 | $102.72 |
| Average True Range (ATR) | 1.72 | 2.38 |
| MACD | -0.01 | -0.09 |
| Stochastic Oscillator | 62.14 | 53.18 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.